Paroxysmal hemicrania in children and adolescents: A systematic review

Maryam Bemanalizadeh1,2, Homayoun Baghaei Oskouei3, Alireza Hadizadeh3

  • 1Child Growth and Development Research Center, Research Institute for Primordial Prevention of Non-Communicable Disease, Isfahan University of Medical Sciences, Isfahan, Iran.

Headache
|July 14, 2022
PubMed

Insights

Pediatric paroxysmal hemicrania (PH) shares similarities with adult PH but presents diagnostic challenges in children. Indomethacin is highly effective for treating pediatric PH, often leading to complete symptom resolution.

Area of Science:

  • Neurology
  • Pediatrics
  • Headache Medicine

Background:

  • Paroxysmal hemicrania (PH) is a rare headache disorder.
  • Understanding pediatric PH characteristics is crucial for accurate diagnosis and management.

Purpose of the Study:

  • To characterize the demographic, clinical, and radiological features of pediatric paroxysmal hemicrania (PH).
  • To compare pediatric PH with adult presentations and identify diagnostic challenges.

Main Methods:

  • Systematic review of PRISMA guidelines.
  • Searched PubMed, Web of Science, and Scopus for English-language studies on pediatric PH.
  • Extracted data on demographics, pain characteristics, symptoms, and treatment response.

Main Results:

  • Analyzed 22 articles representing 35 children/adolescents with PH.
  • Mean age of onset was 6.5 years; mean age of diagnosis was 8.2 years.
  • Indomethacin showed high efficacy, with most patients experiencing complete symptom relief.

Conclusions:

  • Pediatric PH exhibits similarities to adult PH but faces diagnostic challenges with current criteria.
  • Concomitant migrainous features can lead to misdiagnosis as migraine in children.
  • Indomethacin remains the primary and effective treatment for pediatric PH.
Abstract

Related Concept Videos

Mania and Antimanic Drugs: Overview01:24

Mania and Antimanic Drugs: Overview

Mania, a psychological condition characterized by elevated mood, increased energy, and reduced sleep need, is part of the bipolar disorder cycle. The exact cause of mania isn't entirely known, but it is thought to be a combination of genetic, environmental, and neurological factors. Bipolar disorder involves alternating manic and depressive episodes. Mood stabilizers like lithium, antipsychotics, and anticonvulsants help manage these episodes. Lithium carbonate is particularly effective as a...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.